<!DOCTYPE html>
<html lang="en-us">
  <head>
	<meta name="generator" content="Hugo 0.85.0" />
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>fallingstar-Daily-rss | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>fallingstar-Daily-rss</span>
        <span>2024-10-24</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39439148/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241023210141&amp;v=2.18.0.post9&#43;e462414">Validity of self-reported number of pregnancies and maternal age at first birth among females attending organized mammographic screening</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39439148-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241023210141-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Retrospectively recalled survey-based information about number of pregnancies and AFB was highly accurate when validated against prospectively collected information in the MBRN. These survey-based data are valuable for future epidemiological research, and linkage to the MBRN may not be required when these data are &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39439221/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241023210141&amp;v=2.18.0.post9&#43;e462414">Unconventional microRNA role: Enhancing the human leukocyte antigen class I antigen processing pathway via interacting with a silencer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39439221-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241023210141-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39439791/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241023210141&amp;v=2.18.0.post9&#43;e462414">Impact of deceased-donor characteristics on early graft function: outcome of kidney donor pairs accepted for transplantation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39439791-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241023210141-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: The impact of deceased donor characteristics on kidney transplant outcomes is controversial. Correspondingly, the predictive performance of deceased donor scores remains moderate, and many transplant centers lack validated criteria for graft acceptance decisions. To better dissect donor-related risk from recipient and periprocedural variables, we analyzed outcomes of kidney donor pairs transplanted in different &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39440445/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241023210141&amp;v=2.18.0.post9&#43;e462414">Social processes as the missing link: cross-sectionally testing a conceptual model on social mediators of early psychopathological development</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39440445-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241023210141-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Unique associations between risk/protective factors and psychopathology signify the distinct relevance of these factors for youth mental health, whereas the broad associations with social processes support these processes as broad correlates. Results align with the idea of a social pathway toward early psychopathology, although follow-up longitudinal research is required to verify any mediation &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39440883/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241023210141&amp;v=2.18.0.post9&#43;e462414">Toxicities and outcome after CD19-directed chimeric antigen receptor T-cell therapy for secondary neurolymphomatosis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39440883-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241023210141-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Lymphomatous infiltration of the peripheral nervous system (PNS), termed neurolymphomatosis, represents a distinct extranodal non-Hodgkin lymphoma variant with dismal outcome. CD19-directed chimeric antigen receptor (CD19-CAR) T-cell therapy has emerged as a safe and effective treatment for B-cell lymphomas. We aimed to assess toxicity and efficacy of CD19-CAR T-cells in neurolymphomatosis. Neurolymphomatosis patients treated with CD19 CAR T-cells were retrospectively identified at &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39440959/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241023210141&amp;v=2.18.0.post9&#43;e462414">Skin Rejuvenation by Modulation of DNA Methylation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39440959-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241023210141-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Skin aging is driven by a complex set of cellular pathways. Among these, epigenetic mechanisms have garnered particular attention, because of their sensitivity to environmental and lifestyle factors. DNA methylation represents the longest known and best understood epigenetic mechanism. We explain how DNA methylation might function as an interface between the environment and the genome of human skin. Exposures to different environmental factors and lifestyles are known to modulate &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39440970/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241023205824&amp;v=2.18.0.post9&#43;e462414">Procoagulant platelet activation promotes venous thrombosis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39440970-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241023205824-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Platelets are key players in cardiovascular disease and platelet aggregation represents a central pharmacological target, particularly in secondary prevention. However, inhibition of adenosine diphosphate and thromboxane signaling has low efficacy in preventing venous thromboembolism, necessitating the inhibition of the plasmatic coagulation cascade in this disease. Anticoagulation carries a significantly higher risk of bleeding complications, highlighting the need of alternative &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39440991/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241023210141&amp;v=2.18.0.post9&#43;e462414">ETx-22: a novel nectin-4-directed antibody drug conjugate, demonstrates safety and potent antitumor activity in low nectin-4 expressing tumors</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39440991-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241023210141-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Nectin-4 is a cell-adhesion molecule expressed at various levels in many solid tumors, including urothelial cancer. As means to reduce on-target skin toxicity observed with enfortumab vedotin, an anti-nectin-4-MMAE ADC approved for patients with advanced urothelial cancer, 15A7.5, an anti-nectin-4 monoclonal antibody that exhibited differential nectin-4 binding between tumor and primary keratinocytes, was selected for the development of ETx-22. Exatecan, a topoisomerase I inhibitor, was &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39441012/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241023210141&amp;v=2.18.0.post9&#43;e462414">Separation of small extracellular vesicles (sEV) from human blood by Superose 6 size exclusion chromatography</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39441012-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241023210141-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Extracellular vesicles (EVs) are valuable targets for liquid biopsy. However, attempts to introduce EV-based biomarkers into clinical practice have not been successful to the extent expected. One of the reasons for this failure is the lack of reliable methods for EV baseline purification from complex biofluids, such as cell-free plasma or serum. Because available one-step approaches for EV isolation are insufficient to purify EVs, the majority of studies on clinical samples were performed &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39441339/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241023210141&amp;v=2.18.0.post9&#43;e462414">Unilateral obstruction of the nasal sinuses with epistaxis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39441339-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241023210141-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39441354/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241023210141&amp;v=2.18.0.post9&#43;e462414">Impact of a kidney-adjusted ERAS&lt;sup&gt;Â®&lt;/sup&gt; protocol on postoperative outcomes in patients undergoing partial nephrectomy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39441354-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241023210141-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The implementation of a kERAS protocol can have a positive influence on long-term renal function in patients undergoing PN. It can be used safely without promoting AKI. Furthermore, it can be realized with a manageable amount of additional &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39441481/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241023210141&amp;v=2.18.0.post9&#43;e462414">Letter to the Editor Regarding &#39;Tafamidis 61Â mg Patient Characteristics and Persistency? A Retrospective Analysis of German Statutory Health Insurance Data (IQVIAâ„¢ LRx)&#39;</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39441481-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241023210141-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39441526/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241023210141&amp;v=2.18.0.post9&#43;e462414">Sleep disturbances are associated with multiple definitions of long COVID</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39441526-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241023210141-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39441704/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241023210141&amp;v=2.18.0.post9&#43;e462414">Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology consensus review on diagnosis, management, and future directions</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39441704-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241023210141-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Adolescents and young adults (AYAs; ages 15-39 years) are a vulnerable population facing challenges in oncological care, including access to specialized care, transition of care, unique tumor biology, and poor representation in clinical trials. Brain tumors are the second most common tumor type in AYA, with malignant brain tumors being the most common cause of cancer-related death. The 2021 WHO Classification for central nervous system (CNS) Tumors highlights the importance of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39441901/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241023205824&amp;v=2.18.0.post9&#43;e462414">Deuterated water labeling in ibrutinib-treated patients with CLL: leukemia cell kinetics correlate with IGHV, ZAP-70, and MRD</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39441901-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241023205824-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Deuterated (&ldquo;heavy&rdquo;) water labeling in CLL patients demonstrates that IGHV unmutated and ZAP-70-positive patients have higher blood and tissue CLL death rates on ibrutinib therapy, resulting in lower measurable residual disease (MRD) levels with long-term ibrutinib treatment. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39441915/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241023205824&amp;v=2.18.0.post9&#43;e462414">Soluble B-cell maturation antigen levels for disease monitoring in oligosecretory and nonsecretory relapsed multiple myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39441915-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241023205824-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Soluble B-cell maturation antigen (sBCMA) is overexpressed on multiple myeloma (MM) cells. We investigated whether sBCMA levels correlated with other myeloma tumor volume indicators and its utility in monitoring oligo-secretory/non-secretory (O-S/Non-S) MM. In 115 patients with newly diagnosed MM, sBCMA was compared with M-protein levels, bone marrow plasma cells (BMPCs), circulating tumor cells (CTCs), and total diffusion volume (tDV; estimated by whole-body diffusion-weighted &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39441916/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241023205824&amp;v=2.18.0.post9&#43;e462414">CNS Relapse in High-Grade B-cell Lymphoma with MYC and BCL2 Rearrangements and Dark-Zone Signature-Expressing DLBCL</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39441916-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241023205824-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    High-grade B-cell lymphoma with MYC and BCL2 rearrangements (HGBCL-DH-BCL2), or &lsquo;double-hit lymphoma,&rsquo; has been associated with a high risk of central nervous system (CNS) relapse. However, historic estimates are impacted by selection bias. We report CNS relapse rates associated with HGBCL-DH-BCL2 from a population-based cohort with complete fluorescence in situ hybridization testing, as well as diffuse large B-cell lymphoma morphology (DLBCL) tumors expressing the dark-zone gene &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39441941/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241023205824&amp;v=2.18.0.post9&#43;e462414">Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39441941-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241023205824-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Antibiotic-induced microbiome dysbiosis is widespread in oncology, adversely affecting outcomes and side effects of various cancer treatments, including immune checkpoint inhibitors and chimeric antigen receptor T (CAR-T) cell therapies. In this study, we observed that prior exposure to broad-spectrum ABX with extended anaerobic coverage like piperacillin-tazobactam and meropenem was associated with worsened anti-CD19 CAR-T therapy survival outcomes in large B-cell lymphoma patients &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39441941/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241023210141&amp;v=2.18.0.post9&#43;e462414">Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39441941-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241023210141-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Antibiotic-induced microbiome dysbiosis is widespread in oncology, adversely affecting outcomes and side effects of various cancer treatments, including immune checkpoint inhibitors and chimeric antigen receptor T (CAR-T) cell therapies. In this study, we observed that prior exposure to broad-spectrum ABX with extended anaerobic coverage like piperacillin-tazobactam and meropenem was associated with worsened anti-CD19 CAR-T therapy survival outcomes in large B-cell lymphoma patients &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39442042/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241023205827&amp;v=2.18.0.post9&#43;e462414">Burnout, Depression, and Diminished Well-Being among Physicians</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39442042-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241023205827-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39442043/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241023205827&amp;v=2.18.0.post9&#43;e462414">Trichuriasis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39442043-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241023205827-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39442044/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241023205827&amp;v=2.18.0.post9&#43;e462414">Case 33-2024: A 71-Year-Old Woman with Confusion, Aphasia, and a Brain Mass</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39442044-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241023205827-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39442045/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241023205827&amp;v=2.18.0.post9&#43;e462414">FINEARTS-HF - The Latest Masterpiece for MRAs in Heart Failure</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39442045-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241023205827-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39442046/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241023205827&amp;v=2.18.0.post9&#43;e462414">Linking a Neurodevelopmental Disorder with a lncRNA Deletion</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39442046-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241023205827-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39442047/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241023205827&amp;v=2.18.0.post9&#43;e462414">How the Idea of Social Contagion Shaped Trans Medicine</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39442047-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241023205827-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39442048/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241023205827&amp;v=2.18.0.post9&#43;e462414">Rapid Cardiovascular Response to Belzutifan in &lt;em&gt;HIF2A&lt;/em&gt;-Mediated Paraganglioma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39442048-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241023205827-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39442049/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241023205827&amp;v=2.18.0.post9&#43;e462414">Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39442049-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241023205827-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39442050/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241023205827&amp;v=2.18.0.post9&#43;e462414">Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39442050-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241023205827-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39442051/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241023205827&amp;v=2.18.0.post9&#43;e462414">Crinecerfont in Adult Congenital Adrenal Hyperplasia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39442051-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241023205827-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39442052/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241023205827&amp;v=2.18.0.post9&#43;e462414">Crinecerfont in Adult Congenital Adrenal Hyperplasia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39442052-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241023205827-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39442053/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241023205827&amp;v=2.18.0.post9&#43;e462414">Crinecerfont in Adult Congenital Adrenal Hyperplasia. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39442053-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241023205827-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39442054/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241023205827&amp;v=2.18.0.post9&#43;e462414">Parkinson&#39;s Disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39442054-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241023205827-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39442055/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241023205827&amp;v=2.18.0.post9&#43;e462414">Parkinson&#39;s Disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39442055-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241023205827-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39442056/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241023205827&amp;v=2.18.0.post9&#43;e462414">Parkinson&#39;s Disease. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39442056-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241023205827-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OCPDoeCJN">ä»Šå¤©Post Reportsä»‹ç»äº†ä¸€ä¸ªæ–°çš„AIå·¥å…·ï¼ŒGoogleå¼€å‘çš„Notebooklmã€‚æˆ‘ä»¬çŸ¥é“ChatGPTå‡çº§æˆä¸ºChatGPT Plusä»¥åå¯ä»¥ä¸Šä¼ æ–‡ä»¶ï¼Œå¹¶å¤„ç†ä¿¡æ¯ã€‚Notebooklmæ›´è¿›ä¸€æ­¥ï¼Œå®ƒ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ocpdoecjn/">
    
    
    
    
    
      
    
    ä»Šå¤©Post Reportsä»‹ç»äº†ä¸€ä¸ªæ–°çš„AIå·¥å…·ï¼ŒGoogleå¼€å‘çš„Notebooklmã€‚æˆ‘ä»¬çŸ¥é“ChatGPTå‡çº§æˆä¸ºChatGPT Plusä»¥åå¯ä»¥ä¸Šä¼ æ–‡ä»¶ï¼Œå¹¶å¤„ç†ä¿¡æ¯ã€‚Notebooklmæ›´è¿›ä¸€æ­¥ï¼Œå®ƒä¸ä»…æ˜¯å…è´¹çš„ï¼Œä¸éœ€è¦è®¢é˜…è´¹ï¼Œè€Œä¸”å¯ä»¥æŠŠä¸Šä¼ çš„æ–‡ä»¶å±•ç¤ºæˆå„ç§å½¢å¼ï¼Œæ¯”å¦‚å†™æ€»ç»“ã€‚ä½†æœ€è®©äººæƒŠè¯§çš„åŠŸèƒ½æ˜¯å®ƒèƒ½æŠŠä¸€ä¸ªæ–‡ä»¶æˆ–è€…ä¹¦ç±è½¬åŒ–æˆä¸€ä¸ªéå¸¸è‡ªç„¶çš„æ’­å®¢ï¼ˆpodcastï¼‰ï¼Œè®©è™šæ‹Ÿä¸»æŒäººå’Œå˜‰å®¾ä¸€é—®ä¸€ç­”ï¼Œè€Œå¬èµ·æ¥æ¯«æ— AIç—•è¿¹ã€‚Post Reportsä¸»æŒäººç°åœºæµ‹è¯•äº†æŠŠä¸€æœ¬å›­è‰ºä¹¦ç±è½¬åŒ–æˆä¸€ä¸ªpodcastï¼Œèµ·æ‰¿è½¬åˆæ— æ¯”è‡ªç„¶ï¼Œè¿˜æœ‰æ’ç§‘æ‰“è¯¨ã€‚<!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OCUACe2AH">ğŸ”»åŠ æ²™äººè¯´ï¼Œä¹‹å‰æ‰›ç€å—ä¼¤å¦¹å¦¹èµ¤è„šå‰è¡Œçš„åŠ æ²™å°å¥³å­©å’Œå¦¹å¦¹ï¼Œç”±äºè§†é¢‘çš„æ’­å‡ºè€Œå¹¿ä¸ºäººçŸ¥ï¼Œåœ¨éš¾æ°‘è¥å¾—åˆ°äº†æ•‘åŠ©ã€‚ğŸ”»å¥½å¿ƒäººç»™äº†å¥¹ä»¬å¥½å¤šä¸œè¥¿ã€‚ğŸ”»via saeedmhm97...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ocuace2ah/">
    
    
    
    
    
      
    
    ğŸ”»åŠ æ²™äººè¯´ï¼Œä¹‹å‰æ‰›ç€å—ä¼¤å¦¹å¦¹èµ¤è„šå‰è¡Œçš„åŠ æ²™å°å¥³å­©å’Œå¦¹å¦¹ï¼Œç”±äºè§†é¢‘çš„æ’­å‡ºè€Œå¹¿ä¸ºäººçŸ¥ï¼Œåœ¨éš¾æ°‘è¥å¾—åˆ°äº†æ•‘åŠ©ã€‚<!-- raw HTML omitted -->ğŸ”»å¥½å¿ƒäººç»™äº†å¥¹ä»¬å¥½å¤šä¸œè¥¿ã€‚<!-- raw HTML omitted -->ğŸ”»via saeedmhm97<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ä»¥å†›å¯¼å¼¹ç¬é—´ç‚¸å¡Œ10å±‚é«˜æ¥¼#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OCUoJeotr">å®‡é€š//@éš½æ°¸å“‡_lynn:å®‡é€šè¿˜æ˜¯æ¯”äºšè¿ªï¼Ÿ - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:&amp;ensp;ğŸ”»ä¸­å›½æ–°èƒ½æºå®¢è½¦å†å²æ€§åœ°é©¶å…¥åŒ—æåœˆï¼Œåœ¨æŒªå¨æŠ•å…¥æ—¥å¸¸è¿è¥ã€‚ğŸ”»via æ–°åç¤¾è®°è€… li zexin...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ocuojeotr/">
    
    
    
    
    
      
    
    å®‡é€š//<!-- raw HTML omitted -->@éš½æ°¸å“‡_lynn<!-- raw HTML omitted -->:å®‡é€šè¿˜æ˜¯æ¯”äºšè¿ªï¼Ÿ<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»ä¸­å›½æ–°èƒ½æºå®¢è½¦å†å²æ€§åœ°é©¶å…¥åŒ—æåœˆï¼Œåœ¨æŒªå¨æŠ•å…¥æ—¥å¸¸è¿è¥ã€‚<!-- raw HTML omitted -->ğŸ”»via æ–°åç¤¾è®°è€… li zexin <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt;br &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OCUpufAPT">ğŸ”»è¿™å°±æ˜¯ MAGAï¼Œå¬çº¢è„–å­è¯´ã€‚ğŸ”»ä¸€è¾ˆå­ä¹°æªï¼Œå°±ä¸ºäº†è¿™ä¹ˆä¸€å“†å—¦ã€‚ åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ocupufapt/">
    
    
    
    
    
      
    
    ğŸ”»è¿™å°±æ˜¯ MAGAï¼Œå¬çº¢è„–å­è¯´ã€‚<!-- raw HTML omitted -->ğŸ”»ä¸€è¾ˆå­ä¹°æªï¼Œå°±ä¸ºäº†è¿™ä¹ˆä¸€å“†å—¦ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/3fjBoKO1lx08">https://f.video.weibocdn.com/o0/3fjBoKO1lx08</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OCUq2sNMi">ğŸ”»åœŸè€³å…¶çš„åŸƒå°”å¤šå®‰æŠµè¾¾ä¿„ç½—æ–¯ã€‚ğŸ”»å‚åŠ  BRICS å³°ä¼šã€‚ğŸ”»via vk/smotri_media æ–°é—»ç½‘ åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ocuq2snmi/">
    
    
    
    
    
      
    
    ğŸ”»åœŸè€³å…¶çš„åŸƒå°”å¤šå®‰æŠµè¾¾ä¿„ç½—æ–¯ã€‚<!-- raw HTML omitted -->ğŸ”»å‚åŠ  BRICS å³°ä¼šã€‚<!-- raw HTML omitted -->ğŸ”»via vk/smotri_media æ–°é—»ç½‘ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibo">https://f.video.weibo</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OCUqqaCoL">ğŸ”»CNNï¼šç¾å›½å›½é˜²éƒ¨é•¿åŠ³åŸƒå¾·Â·å¥¥æ–¯æ±€è¡¨ç¤ºæœé²œå†›é˜Ÿå·²ç»æŠµè¾¾ä¿„ç½—æ–¯ã€‚ğŸ”»å¥¥æ–¯æ±€è¯´ï¼šâ€œç¾å›½ä»åœ¨è¯•å›¾ç¡®å®šğŸ‡°ğŸ‡µå°†åœ¨å†²çªä¸­æ‰®æ¼”ä»€ä¹ˆè§’è‰²ï¼Œä»¥åŠä»–ä»¬æ˜¯å¦ä¼šå‰å¾€ä¹Œå…‹...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ocuqqacol/">
    
    
    
    
    
      
    
    ğŸ”»CNNï¼šç¾å›½å›½é˜²éƒ¨é•¿åŠ³åŸƒå¾·Â·å¥¥æ–¯æ±€è¡¨ç¤ºæœé²œå†›é˜Ÿå·²ç»æŠµè¾¾ä¿„ç½—æ–¯ã€‚<!-- raw HTML omitted -->ğŸ”»å¥¥æ–¯æ±€è¯´ï¼šâ€œç¾å›½ä»åœ¨è¯•å›¾ç¡®å®šğŸ‡°ğŸ‡µå°†åœ¨å†²çªä¸­æ‰®æ¼”ä»€ä¹ˆè§’è‰²ï¼Œä»¥åŠä»–ä»¬æ˜¯å¦ä¼šå‰å¾€ä¹Œå…‹å…°ã€‚â€<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#æœé²œå¦è®¤å‡ºå…µæ´ä¿„#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OCUrhiyaW">ğŸ”»åŠ æ²™åŒ—éƒ¨çš„ä¸€åå°å¥³å­©åœ¨è¢«ä»¥è‰²åˆ—å†›é˜Ÿå¼ºè¡Œèµ¶å‡ºå®¶å›­åæ³ªæµæ»¡é¢ï¼Œç²¾ç–²åŠ›ç«­ï¼Œæ— æ³•è¡Œèµ°ã€‚ğŸ”»via qudsnen æ–°é—»ç½‘#ä»¥å†›å¯¼å¼¹ç¬é—´ç‚¸å¡Œ10å±‚é«˜æ¥¼# åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ocurhiyaw/">
    
    
    
    
    
      
    
    ğŸ”»åŠ æ²™åŒ—éƒ¨çš„ä¸€åå°å¥³å­©åœ¨è¢«ä»¥è‰²åˆ—å†›é˜Ÿå¼ºè¡Œèµ¶å‡ºå®¶å›­åæ³ªæµæ»¡é¢ï¼Œç²¾ç–²åŠ›ç«­ï¼Œæ— æ³•è¡Œèµ°ã€‚<!-- raw HTML omitted -->ğŸ”»via qudsnen æ–°é—»ç½‘<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ä»¥å†›å¯¼å¼¹ç¬é—´ç‚¸å¡Œ10å±‚é«˜æ¥¼#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OCUsuo1pp">ğŸ”»æ™®äº¬ï¼šâ€œæˆ‘ä»¬æŒ‰ç…§åˆ«äººçš„è§„åˆ™å’Œåœ¨åˆ«äººçš„å¹³å°ä¸Šç”Ÿæ´»çš„æ—¶é—´è¶Šé•¿ï¼Œå‘æ›´å…¬å¹³çš„ç»æµä½“ç³»è¿‡æ¸¡çš„æŒç»­æ—¶é—´å°±è¶Šé•¿ï¼Œè¿™å¯èƒ½ä¼šå¸¦æ¥å·¨å¤§çš„å†²å‡»ï¼Œç‰¹åˆ«æ˜¯æˆ‘ä»¬åœ¨ä¸­ä¸œçœ‹åˆ°çš„å†²...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ocusuo1pp/">
    
    
    
    
    
      
    
    ğŸ”»æ™®äº¬ï¼šâ€œæˆ‘ä»¬æŒ‰ç…§åˆ«äººçš„è§„åˆ™å’Œåœ¨åˆ«äººçš„å¹³å°ä¸Šç”Ÿæ´»çš„æ—¶é—´è¶Šé•¿ï¼Œå‘æ›´å…¬å¹³çš„ç»æµä½“ç³»è¿‡æ¸¡çš„æŒç»­æ—¶é—´å°±è¶Šé•¿ï¼Œè¿™å¯èƒ½ä¼šå¸¦æ¥å·¨å¤§çš„å†²å‡»ï¼Œç‰¹åˆ«æ˜¯æˆ‘ä»¬åœ¨ä¸­ä¸œçœ‹åˆ°çš„å†²å‡»ã€‚â€<!-- raw HTML omitted -->ğŸ”»via vk/smotri_media æ–°é—»ç½‘ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ä¿„ç½—æ–¯äººå¼€å§‹ç”¨ä¸­å›½å¼èŒ¶å…·å–èŒ¶#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a href=&ldquo;<a href="https://video.weibo.c">https://video.weibo.c</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OCUt2e7WG">ğŸ”»æ™®äº¬ï¼šâ€œç¾å…ƒè¢«ç”¨ä½œæ­¦å™¨ï¼Œè¿™æ ·åšçš„äººçŠ¯äº†ä¸€ä¸ªå¤§é”™è¯¯ï¼Œè¿™å‰Šå¼±äº†äººä»¬å¯¹ç¾å…ƒçš„ä¿¡å¿ƒã€‚æˆ‘ä»¬å¹¶ä¸æ˜¯åœ¨å¯¹æŠ—ç¾å…ƒï¼Œä½†å¦‚æœæˆ‘ä»¬ä¸è¢«å…è®¸ä½¿ç”¨ç¾å…ƒï¼Œæˆ‘ä»¬å°±å¿…é¡»å¯»æ‰¾æ›¿ä»£æ–¹...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ocut2e7wg/">
    
    
    
    
    
      
    
    ğŸ”»æ™®äº¬ï¼šâ€œç¾å…ƒè¢«ç”¨ä½œæ­¦å™¨ï¼Œè¿™æ ·åšçš„äººçŠ¯äº†ä¸€ä¸ªå¤§é”™è¯¯ï¼Œè¿™å‰Šå¼±äº†äººä»¬å¯¹ç¾å…ƒçš„ä¿¡å¿ƒã€‚æˆ‘ä»¬å¹¶ä¸æ˜¯åœ¨å¯¹æŠ—ç¾å…ƒï¼Œä½†å¦‚æœæˆ‘ä»¬ä¸è¢«å…è®¸ä½¿ç”¨ç¾å…ƒï¼Œæˆ‘ä»¬å°±å¿…é¡»å¯»æ‰¾æ›¿ä»£æ–¹æ¡ˆã€‚â€<!-- raw HTML omitted -->ğŸ”»via vk/smotri_media æ–°é—»ç½‘ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ä¿„ç½—æ–¯äººå¼€å§‹ç”¨ä¸­å›½å¼èŒ¶å…·å–èŒ¶#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a href=&ldquo;<a href="https://video.weibo.c">https://video.weibo.c</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OCUtRbnWh">ğŸ”»æ™®äº¬ï¼šâ€œæˆ‘ä»¬æè®®å¼€è®¾é‡‘ç –å›½å®¶ç²®é£Ÿäº¤æ˜“æ‰€ï¼Œè¿™å°†æœ‰åŠ©äºå½¢æˆäº§å“å’ŒåŸææ–™çš„å…¬å¹³ä»·æ ¼æŒ‡æ ‡ã€‚â€ğŸ”»[å“†å•¦Aæ¢¦åƒæƒŠ]ğŸ”»via vk/smotri_media æ–°é—»ç½‘ #ä¿„ç½—æ–¯äººå¼€å§‹...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ocutrbnwh/">
    
    
    
    
    
      
    
    ğŸ”»æ™®äº¬ï¼šâ€œæˆ‘ä»¬æè®®å¼€è®¾é‡‘ç –å›½å®¶ç²®é£Ÿäº¤æ˜“æ‰€ï¼Œè¿™å°†æœ‰åŠ©äºå½¢æˆäº§å“å’ŒåŸææ–™çš„å…¬å¹³ä»·æ ¼æŒ‡æ ‡ã€‚â€<!-- raw HTML omitted -->ğŸ”»<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ğŸ”»via vk/smotri_media æ–°é—»ç½‘ <!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%BF%84%E7%BD%97%E6%96%AF%E4%BA%BA%E5%BC%80%E5%A7%8B%E7%94%A8%E4%B8%AD%E5%9B%BD%E5%BC%8F%E8%8C%B6%E5%85%B7%E5%96%9D%E8%8C%B6%23&amp;amp;extparam=%23%E4%BF%84%E7%BD%97%E6%96%AF%E4%BA%BA%E5%BC%80%E5%A7%8B%E7">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%BF%84%E7%BD%97%E6%96%AF%E4%BA%BA%E5%BC%80%E5%A7%8B%E7%94%A8%E4%B8%AD%E5%9B%BD%E5%BC%8F%E8%8C%B6%E5%85%B7%E5%96%9D%E8%8C%B6%23&amp;amp;extparam=%23%E4%BF%84%E7%BD%97%E6%96%AF%E4%BA%BA%E5%BC%80%E5%A7%8B%E7</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OCUuXkc4p">å¥¹è¿˜æ‰ç€å°è¾«å­ã€‚ä½†æ˜¯å¤´å‘å¥½ä¹…æ²¡æ´—è¿‡äº†ã€‚äººå–çš„æ°´éƒ½ä¸å¤Ÿã€‚ - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:&amp;ensp;ğŸ”»åŠ æ²™åŒ—éƒ¨çš„ä¸€åå°å¥³å­©åœ¨è¢«ä»¥è‰²åˆ—å†›é˜Ÿå¼ºè¡Œèµ¶å‡ºå®¶å›­åæ³ªæµæ»¡é¢ï¼Œç²¾ç–²...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ocuuxkc4p/">
    
    
    
    
    
      
    
    å¥¹è¿˜æ‰ç€å°è¾«å­ã€‚ä½†æ˜¯å¤´å‘å¥½ä¹…æ²¡æ´—è¿‡äº†ã€‚äººå–çš„æ°´éƒ½ä¸å¤Ÿã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»åŠ æ²™åŒ—éƒ¨çš„ä¸€åå°å¥³å­©åœ¨è¢«ä»¥è‰²åˆ—å†›é˜Ÿå¼ºè¡Œèµ¶å‡ºå®¶å›­åæ³ªæµæ»¡é¢ï¼Œç²¾ç–²åŠ›ç«­ï¼Œæ— æ³•è¡Œèµ°ã€‚<!-- raw HTML omitted -->ğŸ”»via qudsnen æ–°é—»ç½‘<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ä»¥å†›å¯¼å¼¹ç¬é—´ç‚¸å¡Œ10å±‚é«˜æ¥¼#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OCQvZnYyY">æŸ¯æ´ï¼ˆå…ƒè€èµ›æŠ¢å…ˆä½“éªŒç‰ˆï¼‰ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ocqvznyyy/">
    
    
    
    
    
      
    
    æŸ¯æ´ï¼ˆå…ƒè€èµ›æŠ¢å…ˆä½“éªŒç‰ˆï¼‰ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OCSNBajmv">å¤ªå¥½ç¬‘äº†ï¼Œåˆ åƒåœ¾è´¦å·æ•°æ®æŠŠç®¡ç†å‘˜è´¦å·ç»™åˆ äº†[æ†§æ†¬][æ†§æ†¬][æ†§æ†¬]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ocsnbajmv/">
    
    
    
    
    
      
    
    å¤ªå¥½ç¬‘äº†ï¼Œåˆ åƒåœ¾è´¦å·æ•°æ®æŠŠç®¡ç†å‘˜è´¦å·ç»™åˆ äº†<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[æ†§æ†¬]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/default/d_xingxingyan-c64b6a744b.png%22">https://h5.sinaimg.cn/m/emoticon/icon/default/d_xingxingyan-c64b6a744b.png&quot;</a> style=&ldquo;width:1em; height:1em;&rdquo; referrerpolicy=&ldquo;no-referrer &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OCT2lzfeL">ä½ å°±å­¦å§ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-oct2lzfel/">
    
    
    
    
    
      
    
    ä½ å°±å­¦å§ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">Â© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

